glp 1 receptor agonists (Mimetics)
86
Structured Review
Mimetics
glp 1 receptor agonists
Glp 1 Receptor Agonists, supplied by Mimetics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/glp-1+receptor+agonists/1+agonists+glp+receptor/pm41795462-245-0-4
Average 86 stars, based on 1 article reviews
Glp 1 Receptor Agonists, supplied by Mimetics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/glp-1+receptor+agonists/1+agonists+glp+receptor/pm41795462-245-0-4
Average 86 stars, based on 1 article reviews
glp 1 receptor agonists - by Bioz Stars,
2026-09
86/100 stars
Images
Related Articles
other:Article Title: Current Status of Glucagon-like Peptide-1 Receptor Agonists in Metabolic Dysfunction-associated Steatotic Liver Disease: A Clinical Perspective Article Snippet: GLP-1 receptor agonists (GLP-1RAs), or Article Title: Current and future landscape of heart failure management: understanding the present, unraveling the future. Article Snippet: Current and future landscape of heart failure management: understanding the present, unraveling the future Cristina Madaudo, Daniel Bromage & Antonio Cannata To cite this article: Cristina Madaudo, Daniel Bromage & Antonio Cannata (09 Apr 2025): Current and future landscape of heart failure management: understanding the present, unraveling the future, Future Cardiology, DOI: 10.1080/14796678.2025.2490403 To link to this article: https://doi.org/10.1080/14796678.2025.2490403 Article Title: Editorial: Potentials and Pitfalls in Targeting Glucagon-Like Peptide-1 (GLP-1) in the Management of Increasing Levels of Obesity Article Snippet: This year, the scientific research behind the development of Article Title: Risk of Esophageal and Gastric Cancer in Patients with Type 2 Diabetes Receiving Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs): A National Analysis Article Snippet: GLP-1 agonists, also referred to as GLP-1 receptor agonists (GLP-1 RAs), incretin Article Title: Smart control lipid-based nanocarriers for fine-tuning gut hormone secretion Article Snippet: Over the years, gut hormone Article Title: Targeting Intestinal Neprilysin to Ameliorate Glucose Homeostasis Through Insulinotropic Effect. Article Snippet: Targeting Intestinal Neprilysin to Ameliorate Glucose Homeostasis Through Insulinotropic Effect Shiori Mizuma and Tohru Hira Graduate School of Agriculture, Hokkaido University, Sapporo 060-8589, Japan Research Faculty of Agriculture, Hokkaido University, Sapporo 060-8589, Japan Correspondence: Tohru Hira, PhD, Laboratory of Nutritional Biochemistry, Research Group of Bioscience and Chemistry, Research Faculty of Agriculture, Hokkaido University, Kita-9, Nishi-9, Kita-ku, Sapporo 060-8589, Japan.. Email: hira@eis.hokudai.ac.jp. Article Title: Flavonoids of Mao Jian Green Tea Ameliorate Glycemic Metabolism in Type-2-Diabetic Rats via AMPK Signaling Pathways and Gut Microbiota Regulation. Article Snippet: Oral hypoglycemic medicines are categorized into multiple classes: insulin secretagogues (e.g., sulfonylureas), biguanides (e.g., metformin), insulin sensitizers (e.g., thiazolidinediones), α-glucosidase inhibitors (e.g., acarbose), Article Title: NLRP3 inflammasomes pathway: a key target for Metformin. Article Snippet: Nucleotide-binding oligomerization domain, Leucine rich Repeat and Pyrin domain containing 3 (NLRP3) is a signaling pathway that is involved in inflammatory cascades, cell survival and the immune response.. NLRP3 is activated by cellular damage, oxidative stress, and other factors that stimulate the immune system.. Stimulation of NLRP3 induces inflammatory reactions and the production of inflammatory cytokines. |